Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depressive symptoms in schizophrenia patients: A possible relationship between SIRT1 and BDNF
Xinyu Fang, Yan Chen, Yewei Wang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 95, pp. 109673-109673
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Oxidative Stress‐Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Evgeny A. Ermakov, E. Dmitrieva, D. Parshukova, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 169
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
Rodrigo Nieto, Andrea Carrasco, Sebastián Corral, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 64
More than Addiction—The Nucleus Accumbens Contribution to Development of Mental Disorders and Neurodegenerative Diseases
Martyna Bayassi-Jakowicka, Grażyna Lietzau, Ewelina Czuba, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2618-2618
Open Access | Times Cited: 34
Natural compounds for oxidative stress and neuroprotection in schizophrenia: composition, mechanisms, and therapeutic potential
Anam N. Khan, Rahul D. Jawarkar, Magdi E. A. Zaki, et al.
Nutritional Neuroscience (2024) Vol. 27, Iss. 11, pp. 1306-1320
Closed Access | Times Cited: 6
Neuropharmacological effects of Aconiti Lateralis Radix Praeparata
Lihong Zhao, Zhihui Sun, Limin Yang, et al.
Clinical and Experimental Pharmacology and Physiology (2019) Vol. 47, Iss. 4, pp. 531-542
Closed Access | Times Cited: 43
Whole body vibration training improves depression-like behaviors in a rat chronic restraint stress model
Guangcong Peng, Luodan Yang, Chong Wu, et al.
Neurochemistry International (2020) Vol. 142, pp. 104926-104926
Closed Access | Times Cited: 43
Shared and distinct brain fMRI response during performance of working memory tasks in adult patients with schizophrenia and major depressive disorder
Xiuli Wang, Bochao Cheng, Neil Roberts, et al.
Human Brain Mapping (2021) Vol. 42, Iss. 16, pp. 5458-5476
Open Access | Times Cited: 39
Abnormal regional homogeneity (ReHo) and fractional amplitude of low frequency fluctuations (fALFF) in first-episode drug-naïve schizophrenia patients comorbid with depression
Xinyu Fang, Rongrong Zhang, Chenxi Bao, et al.
Brain Imaging and Behavior (2021) Vol. 15, Iss. 5, pp. 2627-2636
Closed Access | Times Cited: 34
Consensus on potential biomarkers developed for use in clinical tests for schizophrenia
Ping Lin, Junyu Sun, Xiaoyan Lou, et al.
General Psychiatry (2022) Vol. 35, Iss. 1, pp. e100685-e100685
Open Access | Times Cited: 25
MiRNA Differences Related to Treatment-Resistant Schizophrenia
Daniel Pérez-Rodríguez, Maria Aránzazu Penedo, Tania Rivera-Baltanás, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1891-1891
Open Access | Times Cited: 13
Resveratrol, a SIRT1 Activator, Ameliorates MK-801-Induced Cognitive and Motor Impairments in a Neonatal Rat Model of Schizophrenia
Juan Niu, Yuquan Cao, Yong-juan Ji
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 38
Crocin alleviates schizophrenia-like symptoms in rats by upregulating silent information regulator-1 and brain derived neurotrophic factor
Xi-juan Sun, Xin Zhao, Jun-ning Xie, et al.
Comprehensive Psychiatry (2020) Vol. 103, pp. 152209-152209
Open Access | Times Cited: 34
Role of Bmal1 in Type 2 Diabetes Mellitus-Related Glycolipid Metabolic Disorder and Neuropsychiatric Injury: Involved in the Regulation of Synaptic Plasticity and Circadian Rhythms
Xinran Gao, Yadong Wei, Huaizhi Sun, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4595-4617
Closed Access | Times Cited: 12
The SIRT-1/Nrf2/HO-1 Axis: Guardians of Neuronal Health in Neurological Disorders
Pranshul Sethi, Sidharth Mehan, Zuber Khan, et al.
Behavioural Brain Research (2024), pp. 115280-115280
Closed Access | Times Cited: 4
Lactate Mediates Exercise-Induced Modulation of Mitophagy and Ferroptosis, Reducing Amyloid-Beta and Tau in Type 2 Diabetes: A Molecular Study
Kayvan Khoramipour, Pouria Khosravi, Fereshteh Shahidi, et al.
(2025)
Closed Access
Differences in inflammatory marker profiles and cognitive functioning between deficit and nondeficit schizophrenia
Dandan Wang, Yewei Wang, Yan Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Study on correlations of BDNF, PI3K, AKT and CREB levels with depressive emotion and impulsive behaviors in drug-naïve patients with first-episode schizophrenia
Shan Li, Cailian Lu, Lin Kang, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Altered mitochondrial lymphocyte in overweight schizophrenia patients treated with atypical antipsychotics and its association with cognitive function
Yaoyao Zhang, Wei Tang, Bei Tang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Association between cognitive function and skeletal muscle in patients undergoing maintenance hemodialysis
Lulu Wang, Xueqin Bian, Lilin Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1
Martin Law, Peichun Wang, Zhong-Yan Zhou, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1495-1495
Open Access | Times Cited: 3
Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia
Xinyu Fang, Lixian Chen, Dandan Wang, et al.
Psychiatry Research (2019) Vol. 281, pp. 112522-112522
Closed Access | Times Cited: 26
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders
Mirko Manchia, Ulker Isayeva, Roberto Collu, et al.
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1666-1666
Open Access | Times Cited: 15
Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions
Rozaziana Ahmad, Khairunnuur Fairuz Azman, Rosliza Yahaya, et al.
AIMS neuroscience (2023) Vol. 10, Iss. 1, pp. 5-32
Open Access | Times Cited: 8
Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia
Xinzhe Du, Jinzhi Lv, Jianping Feng, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Exploring the link between cognitive deficit, self‐esteem, alexithymia, and depressive symptom of schizophrenia
Chen He, Xueying Zhang, Qingrong Xia, et al.
Brain and Behavior (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top